Overview
STAR-Fusion; bounded primary-source AMP candidate.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Evaluations and results
1 evaluation · 4 results. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: STAR-Fusion | Protocol: EnFusion undiluted Seraseq duplicate benchmark Dataset: Undiluted Seraseq Fusion RNA control, duplicate libraries | 14 mean Seraseq fusions identified fusions · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceConsensus ≥3 callers, with specified filtering and known fusion list rescue; Table 2 displays mean of duplicate undiluted experiments. Only 14 Seraseq fusions are positive; all others counted false positive. Comparators processed by same authors. Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 2, STAR-Fusion row, corresponding column (JATS Tab2) |
| Configuration: STAR-Fusion | Protocol: EnFusion undiluted Seraseq duplicate benchmark Dataset: Undiluted Seraseq Fusion RNA control, duplicate libraries | 32 mean total fusions identified fusions · lower Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceConsensus ≥3 callers, with specified filtering and known fusion list rescue; Table 2 displays mean of duplicate undiluted experiments. Only 14 Seraseq fusions are positive; all others counted false positive. Comparators processed by same authors. Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 2, STAR-Fusion row, corresponding column (JATS Tab2) |
| Configuration: STAR-Fusion | Protocol: EnFusion undiluted Seraseq duplicate benchmark Dataset: Undiluted Seraseq Fusion RNA control, duplicate libraries | 43.6% precision % · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceConsensus ≥3 callers, with specified filtering and known fusion list rescue; Table 2 displays mean of duplicate undiluted experiments. Only 14 Seraseq fusions are positive; all others counted false positive. Comparators processed by same authors. Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 2, STAR-Fusion row, corresponding column (JATS Tab2) |
| Configuration: STAR-Fusion | Protocol: EnFusion undiluted Seraseq duplicate benchmark Dataset: Undiluted Seraseq Fusion RNA control, duplicate libraries | 100% sensitivity % · higher Uncertainty: Not reported Coverage: Not reported scored / Not reported eligible | Independent external evaluation · Source checkedMethods, coverage and sourceConsensus ≥3 callers, with specified filtering and known fusion list rescue; Table 2 displays mean of duplicate undiluted experiments. Only 14 Seraseq fusions are positive; all others counted false positive. Comparators processed by same authors. Aggregation: Not reported Discovery of clinically relevant fusions in pediatric cancer · Table 2, STAR-Fusion row, corresponding column (JATS Tab2) |
Source checking is not independent reproduction. Release 2026-10-07-1448159e6a81.
Use this model
How it works, versions and access
Strengths, limitations and unresolved questions
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
View linked audit checks and correction history
Release 2026-10-07-1448159e6a81 · Record review: source checked
1 source records and release history
- Discovery of clinically relevant fusions in pediatric cancer · Original source · Europe PMC fullTextXML retrieved 2026-10-07T12:25:20.810843+00:00
Technical metadata and extraction receipts
Stable ID: amp-oncology-rna-20261007-issue-11-config-star-fusion
- method types
- conventional_pipeline
- foundation model eligible
- false
- missing metadata
- None recorded
- reported name
- STAR-Fusion
- version
- v1.6.0
Related records
- configuration: STAR-Fusion evaluation